Glenmede Trust Company »

Vaxcyte shares owned by Glenmede Trust Company

Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by Glenmede Trust Company from 13F filings

Historical chart of Glenmede Trust Company investment in Vaxcyte

Tip: Access up to 7 years of quarterly data

All positions including Vaxcyte held by Glenmede Trust Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxcyte by Glenmede Trust Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $810k 12k 68.31
2023-09-30 $762k 15k 50.98

More positions owned by Glenmede Trust Company

Microsoft Corporation (MSFT)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p Scp Etf (IJR)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Index Fds Small Cp Etf (VB)
Home Depot (HD)
Procter & Gamble Company (PG)
Accenture Plc Ireland Shs Class A (ACN)

View all positions for Glenmede Trust Company

Top funds holding Vaxcyte

FMR
Vanguard Group
BlackRock
RA Capital Management
Henderson Group
Wellington Management Company
Capital Research Global Investors
T. Rowe Price Investment Management
State Street Corporation
T. Rowe Price Associates
Darwin Global Management
Geode Capital Management
Franklin Resources
Perceptive Advisors
Driehaus Capital Management

View all funds holding Vaxcyte